Even the most promising vaccines don’t always make it out of the laboratory into large-scale production. We at Intravacc are fully aware of the challenges on the long road of vaccine development.
We substantially reduce the risks and costs involved with developing vaccines. How? By bridging the gap between your concept and late stage clinical studies.
As an established independent CDMO in the vaccine industry, Intravacc offers a wide range of expertise and is the bridge between your discovery and the start of your phase I/II clinical trials in humans.
Part of Utrecht Science Park Bilthoven
Company Details
- Employees
- 63
- Founded
- -
- Address
- Antonie Van Leeuwenhoeklaan 9, Bilthoven,utrecht 3721 Ma,netherlands
- Phone
- +31 30 7920 300
- in****@****vacc.nl
- Industry
- Biotechnology Research
- NAICS
-
Research and Development in Biotechnology (except Nanobiotechnology)
- Website
- intravacc.nl
- Keywords
- Vaccinology, Healthcare, R&D, Platform Technology.
- HQ
- Bilthoven, Utrecht
Intravacc Questions
Intravacc's helpline number is +31 30 7920 300
Intravacc's website is intravacc.nl
Intravacc's LinkedIn profile is https://nl.linkedin.com/company/intravacc
Intravacc has
63 employees.
View email and phone details for 63
employees at Intravacc.
Intravacc's industry is
Biotechnology Research
Intravacc's top competitors are
Batavia Biosciences,
Necstgen,
Uniqure,
Vectory,
Molsid,
Genmab,
Galapagos,
Halix,
Lava Therapeutics N.v.,
Bilthoven Biologicals.
Intravacc's support email address is info@intravacc.nl
Intravacc's categories are Biotechnology Research
Intravacc's founding year is 2013
